TFAP2B, AP-1 and JAZF1 Expression in Tissues of Papillary Thyroid Carcinoma Patients; Clinical, Pathological and Prognostic Values

Overview

Journal Asian Pac J Cancer Prev

Specialty Oncology

Date 2020 Aug 29

PMID 32856873

Citations 1

Authors

Abdulwahab A Abuderman

Ola A Harb

Loay M Gertallah

Nahlah Makki Almansour

Affiliations

Soon will be listed here.

Abstract

Objective: Transcription factor activating protein 2 B (TFAP2 B) is a transcription factor that regulates many steps of embryogenesis, cell growth, apoptosis and recently oncogenesis and cancer progression. AP-1 is a transcription factor that is a downstream molecule of the MAPK signaling pathway. Juxtaposed with zinc finger gene 1 (JAZF1) is a recently detected transforming growth factor which has a role in carcinogenesis. Hence the present study aimed to assess those markers expression in tissues from patients with such cancer correlation their expression with clinic-pathological findings of the tumor and prognostic and follow-up findings of patients.

Methods: We have collected tissue samples from papillary thyroid cancer patients and adjacent non-neoplastic tissues from 80 patients. We assessed the expression of TFAP2B, AP-1 and JAZF1 using immunohistochemistry.

Results: Expression of TFAP2B was positively associated with lymph nodes metastases (p=0.003), distant metastases (p=0.002), recurrence of the tumor (p=0.002), unfavourable disease-free survival rate (p=0.003). AP-1 expression is positively associated with advanced stage (p=0.002), presence of extra-thyroid invasion (p=0.005), recurrence of the tumor (p=0.005), unfavorable disease-free survival rate (p=0.01). JAZF1 expression is negatively associated with huge tumor size (0.023), vascular invasion (p=0.007) and unfavorable overall survival rate (p=.030).

Conclusion: High expression levels of TFAP2B and AP-1 and low expression levels of JAZF1 were associated with unfavourable pathological, prognostic parameters and dismal patient's outcome.<br />.

Citing Articles

Causality-driven candidate identification for reliable DNA methylation biomarker discovery.

Tang X, Guo R, Mo Z, Fu W, Qian X Nat Commun. 2025; 16(1):680.

PMID: 39814752 PMC: 11735613. DOI: 10.1038/s41467-025-56054-y.

To Explore the Inhibitory Mechanism of Quercetin in Thyroid Papillary Carcinoma through Network Pharmacology and Experiments.

Sun Y, Xie W, Kang N, Yi J, Ruan X, Hu L Dis Markers. 2022; 2022:9541080.

PMID: 36510497 PMC: 9741536. DOI: 10.1155/2022/9541080.

References

Fu L, Shi K, Wang J, Chen W, Shi D, Tian Y . TFAP2B overexpression contributes to tumor growth and a poor prognosis of human lung adenocarcinoma through modulation of ERK and VEGF/PEDF signaling. Mol Cancer. 2014; 13:89. PMC: 4021500. DOI: 10.1186/1476-4598-13-89. View

Huang L, Cai Y, Luo Y, Xiong D, Hou Z, Lv J . JAZF1 Suppresses Papillary Thyroid Carcinoma Cell Proliferation and Facilitates Apoptosis via Regulating TAK1/NF-κB Pathways. Onco Targets Ther. 2019; 12:10501-10514. PMC: 6897071. DOI: 10.2147/OTT.S230597. View

Hodge J, Bedroske P, Pearce K, Sukov W . Molecular Cytogenetic Analysis of JAZF1, PHF1, and YWHAE in Endometrial Stromal Tumors: Discovery of Genetic Complexity by Fluorescence in Situ Hybridization. J Mol Diagn. 2016; 18(4):516-26. DOI: 10.1016/j.jmoldx.2016.02.001. View

Xiao C, Huang Y, Gao Q, Feng Z, Li Q, Liu Z . Expression of activator protein-1 in papillary thyroid carcinoma and its clinical significance. World J Surg Oncol. 2019; 17(1):25. PMC: 6357454. DOI: 10.1186/s12957-019-1568-x. View

Chen X, Wu W, Chen X, Gong X . Roles of phosphatidylinositol 3-kinase regulatory subunit alpha, activator protein-1, and programmed cell death 4 in diagnosis of papillary thyroid carcinoma. Tumour Biol. 2015; 37(5):6519-26. DOI: 10.1007/s13277-015-4476-x. View

Yuasa K, Aoki N, Hijikata T . JAZF1 promotes proliferation of C2C12 cells, but retards their myogenic differentiation through transcriptional repression of MEF2C and MRF4-Implications for the role of Jazf1 variants in oncogenesis and type 2 diabetes. Exp Cell Res. 2015; 336(2):287-97. DOI: 10.1016/j.yexcr.2015.06.009. View

Hazelett D, Rhie S, Gaddis M, Yan C, Lakeland D, Coetzee S . Comprehensive functional annotation of 77 prostate cancer risk loci. PLoS Genet. 2014; 10(1):e1004102. PMC: 3907334. DOI: 10.1371/journal.pgen.1004102. View

Nakajima T, Fujino S, Nakanishi G, Kim Y, Jetten A . TIP27: a novel repressor of the nuclear orphan receptor TAK1/TR4. Nucleic Acids Res. 2004; 32(14):4194-204. PMC: 514368. DOI: 10.1093/nar/gkh741. View

Karjalainen J, Kellokoski J, Mannermaa A, Kujala H, Moisio K, Mitchell P . Failure in post-transcriptional processing is a possible inactivation mechanism of AP-2alpha in cutaneous melanoma. Br J Cancer. 2000; 82(12):2015-21. PMC: 2363258. DOI: 10.1054/bjoc.2000.1145. View

10.

Tellez C, McCarty M, Ruiz M, Bar-Eli M . Loss of activator protein-2alpha results in overexpression of protease-activated receptor-1 and correlates with the malignant phenotype of human melanoma. J Biol Chem. 2003; 278(47):46632-42. DOI: 10.1074/jbc.M309159200. View

11.

Pospiech K, Pluciennik E, Bednarek A . Tumor Suppressor Gene in Breast Cancer, a Historical Perspective and Future Directions. Front Oncol. 2018; 8:345. PMC: 6121138. DOI: 10.3389/fonc.2018.00345. View

12.

Ito Y, Kudo T, Kobayashi K, Miya A, Ichihara K, Miyauchi A . Prognostic factors for recurrence of papillary thyroid carcinoma in the lymph nodes, lung, and bone: analysis of 5,768 patients with average 10-year follow-up. World J Surg. 2012; 36(6):1274-8. DOI: 10.1007/s00268-012-1423-5. View

13.

Nikbakht Dastjerdi PhD M, Azarnezhad PhD A, Hashemibeni PhD B, Salehi PhD M, Kazemi PhD M, Babazadeh PhD Z . An Effective Concentration of 5-Aza-CdR to Induce Cell Death and Apoptosis in Human Pancreatic Cancer Cell Line through Reactivating RASSF1A and Up-Regulation of Bax Genes. Iran J Med Sci. 2018; 43(5):533-540. PMC: 6123548. View

14.

Shin W, Hong Y, Lee H, Lee S . Catalytically defective receptor protein tyrosine kinase PTK7 enhances invasive phenotype by inducing MMP-9 through activation of AP-1 and NF-κB in esophageal squamous cell carcinoma cells. Oncotarget. 2016; 7(45):73242-73256. PMC: 5341976. DOI: 10.18632/oncotarget.12303. View

15.

Fu X, Zhang H, Chen Z, Yang Z, Shi D, Liu T . TFAP2B overexpression contributes to tumor growth and progression of thyroid cancer through the COX-2 signaling pathway. Cell Death Dis. 2019; 10(6):397. PMC: 6529436. DOI: 10.1038/s41419-019-1600-7. View

16.

Luo Z, Rhie S, Lay F, Farnham P . A Prostate Cancer Risk Element Functions as a Repressive Loop that Regulates HOXA13. Cell Rep. 2017; 21(6):1411-1417. PMC: 5726543. DOI: 10.1016/j.celrep.2017.10.048. View

17.

Qiu J, Li X, He Y, Sun D, Li W, Xin Y . Distinct subgroup of the Ras family member 3 (DIRAS3) expression impairs metastasis and induces autophagy of gastric cancer cells in mice. J Cancer Res Clin Oncol. 2018; 144(10):1869-1886. PMC: 6153597. DOI: 10.1007/s00432-018-2708-3. View

18.

Jang W, Bae K, Kim S, Yu D, Kim H, Ji Y . Overexpression of Jazf1 reduces body weight gain and regulates lipid metabolism in high fat diet. Biochem Biophys Res Commun. 2014; 444(3):296-301. DOI: 10.1016/j.bbrc.2013.12.094. View

19.

Tewari D, Nabavi S, Nabavi S, Sureda A, Farooqi A, Atanasov A . Targeting activator protein 1 signaling pathway by bioactive natural agents: Possible therapeutic strategy for cancer prevention and intervention. Pharmacol Res. 2017; 128:366-375. DOI: 10.1016/j.phrs.2017.09.014. View

20.

Daft P, Yang Y, Napierala D, Zayzafoon M . The growth and aggressive behavior of human osteosarcoma is regulated by a CaMKII-controlled autocrine VEGF signaling mechanism. PLoS One. 2015; 10(4):e0121568. PMC: 4393114. DOI: 10.1371/journal.pone.0121568. View